Association of Baseline MRI PI-RADS Score With Prostate Cancer Active Surveillance Early Biopsy Reclassification: Data From the Michigan Urological Surgery Improvement Collaborative (MUSIC)
Uro-Oncology
Related content
Uro-OncologyFurther Publications Urology
Detection of clinically significant prostate cancer following initial omission of biopsy in multiparametric MRI era
Prostate Cancer Prostatic Dis
Li EV, Busza AM, Siddiqui MR, Aguiar JA, Keeter MK, Neill C, Kumar SK, Mi X, Schaeffer EM, Patel HD, Ross AE
doi: 10.1038/s41391-024-00853-9
Uro-Oncology
The detection rate for prostate cancer in systematic and targeted prostate biopsy in biopsy-naive patients, according to the localization of the lesion at the mpMRI: A single-center retrospective observational study
Prostate
Massanova M, Barone B, Caputo VF, Napolitano L, Ponsiglione A, Del Giudice F, Ferro M, Lucarelli G, Lasorsa F, Busetto GM, Robertson S, Trama F, Imbimbo C, Crocetto F
doi: 10.1002/pros.24761
Further Publications Urology
Outcomes of Salvage Robotic-assisted Radical Prostatectomy: High-volume Multicentric Data from the European Association of Urology Robotic Urology Section Scientific Working Group
Eur Urol
Covas Moschovas M, Saikali S, Sandri M, Bravi C, Falagario U, Nathan A, Collins J, Balestrazzi E, de Naeyer G, Groote R, Chiara Sighinolfi M, Knipper S, Graefen M, Pose R, Ploussard G, Idais H, John H, Mottaran A, Schiavina R, Piazza P, Brunocilla E, Breda A, Rocco B, Harke NN, Mottrie A, Nathan S, Patel V, Wiklund P
doi: 10.1016/j.eururo.2025.03.009
Uro-OncologyFurther Publications Urology
Association of Genomic Prostate Score at positive margin with recurrence after radical prostatectomy
BJU Int
Nourmohammadi Abadchi S, Salles DC, Flannery C, Sama V, Baehner FL, Zambon JP, Mendes AA, DePaula Oliveira L, Han M, Jing Y, Partin AW, Trock BJ, Lotan TL
doi: 10.1111/bju.16445
Benign Prostatic Hyperplasia (BPH)
The Prostate Microbiome Is Associated With Prostate Size and PSA Level, Independent of Age, in BPH Patients
Prostate
Sun A, Rodriguez-Alvarez JS, Harper S, Khooblall P, Dang T, De S, Miller AW
doi: 10.1002/pros.24891
Uro-Oncology
Hypofractionated radiotherapy for prostate cancer (HYDRA): an individual patient data meta-analysis of randomised trials in the MARCAP consortium
Lancet Oncol
Kishan AU, Sun Y, Tree AC, Hall E, Dearnaley D, Catton CN, Lukka HR, Pond G, Lee WR, Sandler HM, Feng FY, Nguyen PL, Incrocci L, Heemsbergen W, Pos FJ, Horwitz E, Wong JK, Hoffman KE, Hassanzadeh C, Kuban DA, Arcangeli S, Sanguineti G, Supiot S, Crehange G, Latorzeff I, Kalbasi TR, Steinberg ML, Valle LF, Loblaw A, Nikitas J, Roy S, Zaorsky NG, Jia AY, Spratt DE
doi: 10.1016/S1470-2045(25)00034-8
Benign Prostatic Hyperplasia (BPH)
Do Prostate Imaging-Reporting and Data System (PIRADS) lesions predict holmium laser enucleation of prostate outcomes?
Prostate
Tsai K, Xu P, Guo J, Dean N, Khondakar N, Michael J, Neill C, Krambeck A
doi: 10.1002/pros.24771
COMMENTED
Uro-Oncology
Effects of Enzalutamide on the Sexual Activity of Patients with Biochemically Recurrent Prostate Cancer: A Post Hoc Analysis of Patient-reported Outcomes in the EMBARK Study
★ 1
Recommended and commented by
Prof. Dr Richard Cathomas, Faculty Member
Eur Urol
Freedland SJ, Mulhall JP, Gleave M, Giorgi U, Saad F, Rannikko A, Ivanova JI, Nasr AF, Reisman AL, Ganguli A, Kral P, Turnbull J, Shore N
doi: 10.1016/j.eururo.2025.02.006
Uro-Oncology
Outcome of Subsequent Therapies After (177)Lu-Vipivotide Tetraxetan for Metastatic Castrate-Resistant Prostate Cancer: A Tertiary Cancer Center Experience
Prostate
Losee M, Kavanaugh M, Liu M, Borges N, Haberman V, Ritzer J, Wolanski A, Bhimaniya S, Choudhury AD, Hyun H, Stoltenberg H, Kilbridge KL, Morgans A, Pomerantz M, Robertson M, Sakellis C, Shah H, Taplin ME, Wei XX, Ng T, Ravi P, Jacene H
doi: 10.1002/pros.24880